Lee S - Search Results

1

Trans-fused 5-[(tert-Butoxtycarbonyl)amino]octahydroindenes as a protease activated receptor-1 (PAR1) antagonist.

Park CM, Baek S, Kim S, Song JH, Lee S, Kim M. Park CM, et al. Among authors: lee s. Arch Pharm Res. 2016 Sep;39(9):1275-95. doi: 10.1007/s12272-016-0788-7. Epub 2016 Jul 12. Arch Pharm Res. 2016. PMID: 27406140

2

Octahydrocyclopenta[c]pyridine and octahydrocyclopenta[c]pyran analogues as a protease activated receptor 1 (PAR1) antagonist.

Wadood A, Kim H, Park CM, Song JH, Lee S. Wadood A, et al. Among authors: lee s. Arch Pharm Res. 2015 Nov;38(11):2029-41. doi: 10.1007/s12272-015-0623-6. Epub 2015 Jun 12. Arch Pharm Res. 2015. PMID: 26068939

3

Discovery of Octahydroindenes as PAR1 Antagonists.

Lee S, Song JH, Park CM, Kim JS, Jeong JH, Cho WY, Lim DC. Lee S, et al. ACS Med Chem Lett. 2013 Sep 10;4(11):1054-8. doi: 10.1021/ml400235c. eCollection 2013 Nov 14. ACS Med Chem Lett. 2013. PMID: 24900604 Free PMC article.

4

Discovery of 4-(phenyl)thio-1H-pyrazole derivatives as agonists of GPR109A, a high affinity niacin receptor.

Kim HY, Jadhav VB, Jeong DY, Park WK, Song JH, Lee S, Cho H. Kim HY, et al. Among authors: lee s. Arch Pharm Res. 2015 Jun;38(6):1019-32. doi: 10.1007/s12272-015-0560-4. Epub 2015 Jan 20. Arch Pharm Res. 2015. PMID: 25599616

5

Discovery of 4-hydroxy-2-oxo-1,2-dihydroquinolines as potential inhibitors of Streptococcus pneumoniae, including drug-resistant strains.

Huddar S, Park CM, Kim HJ, Jang S, Lee S. Huddar S, et al. Among authors: lee s. Bioorg Med Chem Lett. 2020 May 1;30(9):127071. doi: 10.1016/j.bmcl.2020.127071. Epub 2020 Feb 29. Bioorg Med Chem Lett. 2020. PMID: 32146051

6

Discovery of an orally available PAR-1 antagonist as a novel antiplatelet agent.

Lee S. Lee S. Arch Pharm Res. 2011 Apr;34(4):515-7. doi: 10.1007/s12272-011-0421-8. Arch Pharm Res. 2011. PMID: 21544715 Review.

7

Anticancer Activity of Pyrimethamine via Ubiquitin Mediated Degradation of AIMP2-DX2.

Kim DG, Park CM, Huddar S, Lim S, Kim S, Lee S. Kim DG, et al. Among authors: lee s. Molecules. 2020 Jun 15;25(12):2763. doi: 10.3390/molecules25122763. Molecules. 2020. PMID: 32549310 Free PMC article.

8

Allosteric Inhibition of the Tumor-Promoting Interaction Between Exon 2-Depleted Splice Variant of Aminoacyl-Transfer RNA Synthetase-Interacting Multifunctional Protein 2 and Heat Shock Protein 70.

Kim DG, Huddar S, Lim S, Kong J, Lee Y, Park CM, Lee S, Suh YG, Kim M, Lee K, Lee S, Kim S. Kim DG, et al. Among authors: lee y, lee k, lee s. J Pharmacol Exp Ther. 2021 Dec;379(3):358-371. doi: 10.1124/jpet.121.000766. Epub 2021 Sep 9. J Pharmacol Exp Ther. 2021. PMID: 34503993

9

Chemical suppression of an oncogenic splicing variant of AIMP2 induces tumour regression.

Lee HS, Kim DG, Oh YS, Kwon NH, Lee JY, Kim D, Park SH, Song JH, Lee S, Han JM, Park BJ, Lee J, Kim S. Lee HS, et al. Among authors: lee j, lee jy, lee s. Biochem J. 2013 Sep 15;454(3):411-6. doi: 10.1042/BJ20130550. Biochem J. 2013. PMID: 23815603

10

KR-31378, a novel benzopyran analog, attenuates hypoxia-induced cell death via mitochondrial KATP channel and protein kinase C-epsilon in heart-derived H9c2 cells.

Moon CH, Kim MY, Kim MJ, Kim MH, Lee S, Yi KY, Yoo SE, Lee DH, Lim H, Kim HS, Lee SH, Baik EJ, Jung YS. Moon CH, et al. Among authors: lee sh, lee dh, lee s. Eur J Pharmacol. 2004 Dec 3;506(1):27-35. doi: 10.1016/j.ejphar.2004.10.037. Eur J Pharmacol. 2004. PMID: 15588621

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

133,074 results

Search Page

Filters